Ardigen

We’re thrilled to announce that through our ONCOactive DAYS 2024 initiative, Ardigen not only met our initial goal of 900 kilometers but reached an incredible 2,993 kilometers—more than triple our target! 🚴♀️🏃♂️ Thanks to the amazing dedication of everyone involved in ONCOactive DAYS 2024, we can support two fantastic foundations. Ardigen will donate to Fundacja Onkologiczna Cancer Fighters, which will fund specialized equipment for the Clinic of Pediatrics, Oncology, and Pediatric, and to Fundacja Na Ratunek Dzieciom z Chorobą Nowotworową helping to reprint a heartfelt guide for children with cancer and their families. Thank you for being part of this journey and helping us make a meaningful impact.  #ONCOactiveDays #MakingADifference #Ardigen

🔍 Are you overwhelmed by data overload in drug discovery? Join us next week for our webinar, From Data Overload to Decision Clarity in Drug Discovery! Discover how AI-driven tools and streamlined data management can cut down on experiments and accelerate breakthroughs. Whether you're dealing with endless Excel files or fragmented lab data, we’ll show you how to turn data into a true discovery engine. Our experts, Jan Majta and Błażej Szczerba, who work with these challenges daily, will be there to share insights and answer your questions. 📅 November 12, 5pm CET / 11am ET – Register now and take your research to the next level! #DrugDiscovery #AI #Biotech #Pharma #Webinar

Catch up with Kaja Milanowska-Zabel, Ph.D., MBA and Joanna Marczyńska-Grzelak to discuss innovations in protein and antibody research at #PEGSEurope!

In October, Ardigen and our entire team celebrated a special event—we opened a new office in Krakow! The grand opening brought together an inspiring mix of our partners, distinguished guests, and talented team members from around the world. It was a powerful moment of connection, celebration, and shared purpose, reinforcing our collective drive to innovate and make a lasting impact. Today, we’re excited to share moments from that day, including a photo story and video highlights. Check out the full gallery on our website! 📸✨ https://lnkd.in/dPA9Rtn6 #NewOffice #Ardigen #Biotechnology #AI

We’re pleased to share that Tomasz Jetka, PhD, Director of Data Science at Ardigen, will be participating in the upcoming Lab Futures Forum—monthly live-streamed events focused on the latest in lab automation for AI-driven drug discovery and pharmaceutical innovation. Tomasz will be discussing the real-world impact of combining automated lab experiments with in silico approaches, drawing from case studies with Ardigen’s partners. He’ll highlight the challenges and benefits of data science in biotech and how AI tools can support biologists and chemists, featuring the AI-Lab Loop as a model for enhancing workflows and speeding up drug discovery. Be sure to tune in to gain practical insights! You can register here: https://lnkd.in/dt5Ui-en #AI #DrugDiscovery #LabAutomation #PharmaceuticalInnovation Automata

A stunning 9 out of 10 drug candidates fail at the clinical stage, and one of the biggest reasons for failure is poor #TargetIdentification. 🎯 Identifying the right target can make or break your drug discovery program. Advances in #AI and #MachineLearning are revolutionizing how we approach target ID, from identifying novel targets to evaluating their therapeutic potential. With AI and ML tools, you can take your target identification to the next level: - Reveal patterns and insights from complex datasets - Identify therapeutically relevant targets - Rank targets according to their therapeutic potential - Evaluate the safety of your target - Predict drug responses in vivo from preclinical data - This blog post dives deep into the role of ML and AI in optimizing target identification. Click to learn how it can help you minimize risk and accelerate the process of drug discovery and development:  https://lnkd.in/egRZctXU

The #Nextflow Summit has just kicked off! You’ll find our team there— Kamil Malisz will be presenting his talk on advancing open science in Big Pharma, alongside Sean Melville and Błażej Szczerba, who are ready to engage and share insights. Why Nextflow? It’s a game-changer in managing and automating complex bioinformatics workflows, making data processing more efficient and scalable. At Ardigen, we provide comprehensive support for Nextflow setup, deployment, and custom workflow development to help you get the most out of your data. If you’re at the summit, make sure to say hello and come to our booth! #NextflowSummit #Bioinformatics #DataScience #WorkflowAutomation

Today marks the first day of the LSBC Conference in Krakow, where industry leaders are convening to discuss the evolving role of AI in the life sciences sector. Our CTO, Michal Warchol, is participating in a panel that addresses how AI is revolutionizing CRO services, enhancing data analysis, and streamlining processes from lab to clinic. Moderated by Skye Hodson from Syneos Health, UK, the panel also includes Florian Jaeckle from Lyzeum, UK, Zara Liew from Lindus Health, UK, Lukasz Partyka from KCRI, Poland, and Maya Zlatanova from FindMeCure and TrialHub, Bulgaria. Panelists emphasized AI's potential to reduce the time to market for new therapies, while also acknowledging the challenges of integrating these technologies into existing workflows. Key issues such as data quality and interoperability must be addressed to fully realize AI's benefits. The discussions highlighted the importance of collaboration between tech firms and biopharmaceutical companies to effectively leverage AI capabilities. As AI technologies continue to evolve, adapting regulatory frameworks will be crucial to ensure patient safety while fostering innovation. We believe that continued dialogue and collaboration will be essential in creating a successful life sciences environment amid the upcoming technological changes, and we are excited to be in places like today to support this transformation. #AI #LifeScience #CRO #Innovation

Challenging how we think about innovation is key. Jan Majta's approach of focusing on the right questions rather than just the solution offers a refreshing perspective. Definitely worth listening to if you're looking for new ways to approach problem-solving in bioinformatics!

We just returned from the Festival of Biologics in Basel, where industry leaders, scientists and innovators gathered to discuss the innovations shaping the industry. Check out our latest blog post for conference highlights and key takeaways on how AI is driving advancements in biologics research, discovery and development. https://lnkd.in/dJthSNDh It was a pleasure connecting with so many of you at the event! If we missed the chance to chat, don’t hesitate to reach out—we’d love to discuss your projects and see how we can help bring them to life. #FOB2024 Kaja Milanowska-Zabel, Ph.D., MBA; Maciej Jasinski